Inhibition of SARS-CoV-2 3CL protease by the anti-viral chimeric protein RetroMAD1
COVID-19 results from SARS-CoV-2, which mutates frequently, challenging current treatments. Therefore, it is critical to develop new therapeutic drugs against this disease. This study explores the interaction between SARS-CoV-2 3CLpro and RetroMAD1, a well-characterized coronavirus protein and poten...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Published: |
Nature Research
2023
|